234 related articles for article (PubMed ID: 34899741)
21. Promises and Challenges of Smac Mimetics as Cancer Therapeutics.
Fulda S
Clin Cancer Res; 2015 Nov; 21(22):5030-6. PubMed ID: 26567362
[TBL] [Abstract][Full Text] [Related]
22. Proteasome inhibitors and Smac mimetics cooperate to induce cell death in diffuse large B-cell lymphoma by stabilizing NOXA and triggering mitochondrial apoptosis.
Dietz A; Dalda N; Zielke S; Dittmann J; van Wijk SJL; Vogler M; Fulda S
Int J Cancer; 2020 Sep; 147(5):1485-1498. PubMed ID: 32170726
[TBL] [Abstract][Full Text] [Related]
23. Selective cell death of latently HIV-infected CD4
Zhang G; Luk BT; Wei X; Campbell GR; Fang RH; Zhang L; Spector SA
Cell Death Dis; 2019 May; 10(6):419. PubMed ID: 31142734
[TBL] [Abstract][Full Text] [Related]
24. Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs).
Rathore R; McCallum JE; Varghese E; Florea AM; Büsselberg D
Apoptosis; 2017 Jul; 22(7):898-919. PubMed ID: 28424988
[TBL] [Abstract][Full Text] [Related]
25. Smac mimetic SM-164 potentiates APO2L/TRAIL- and doxorubicin-mediated anticancer activity in human hepatocellular carcinoma cells.
Zhang S; Li G; Zhao Y; Liu G; Wang Y; Ma X; Li D; Wu Y; Lu J
PLoS One; 2012; 7(12):e51461. PubMed ID: 23240027
[TBL] [Abstract][Full Text] [Related]
26. Potency and Selectivity of SMAC/DIABLO Mimetics in Solid Tumor Therapy.
Zhao XY; Wang XY; Wei QY; Xu YM; Lau ATY
Cells; 2020 Apr; 9(4):. PubMed ID: 32325691
[TBL] [Abstract][Full Text] [Related]
27. Characterization of Potent SMAC Mimetics that Sensitize Cancer Cells to TNF Family-Induced Apoptosis.
Welsh K; Milutinovic S; Ardecky RJ; Gonzalez-Lopez M; Ganji SR; Teriete P; Finlay D; Riedl S; Matsuzawa S; Pinilla C; Houghten R; Vuori K; Reed JC; Cosford ND
PLoS One; 2016; 11(9):e0161952. PubMed ID: 27617834
[TBL] [Abstract][Full Text] [Related]
28. Killing HIV-infected resting central memory CD4
Zhang G; Huang X
Antivir Chem Chemother; 2021; 29():2040206620980888. PubMed ID: 33557588
[TBL] [Abstract][Full Text] [Related]
29. Design of small-molecule Smac mimetics as IAP antagonists.
Wang S
Curr Top Microbiol Immunol; 2011; 348():89-113. PubMed ID: 21072626
[TBL] [Abstract][Full Text] [Related]
30. Molecular pathways: targeting death receptors and smac mimetics.
Fulda S
Clin Cancer Res; 2014 Aug; 20(15):3915-20. PubMed ID: 24824309
[TBL] [Abstract][Full Text] [Related]
31. Smac mimetics as IAP antagonists.
Fulda S
Semin Cell Dev Biol; 2015 Mar; 39():132-8. PubMed ID: 25550219
[TBL] [Abstract][Full Text] [Related]
32. Designing Smac-mimetics as antagonists of XIAP, cIAP1, and cIAP2.
Cossu F; Mastrangelo E; Milani M; Sorrentino G; Lecis D; Delia D; Manzoni L; Seneci P; Scolastico C; Bolognesi M
Biochem Biophys Res Commun; 2009 Jan; 378(2):162-7. PubMed ID: 18992220
[TBL] [Abstract][Full Text] [Related]
33. Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4
Madrid-Elena N; García-Bermejo ML; Serrano-Villar S; Díaz-de Santiago A; Sastre B; Gutiérrez C; Dronda F; Coronel Díaz M; Domínguez E; López-Huertas MR; Hernández-Novoa B; Moreno S
J Virol; 2018 May; 92(9):. PubMed ID: 29444937
[TBL] [Abstract][Full Text] [Related]
34. A novel SMAC mimetic APG-1387 exhibits dual antitumor effect on HBV-positive hepatocellular carcinoma with high expression of cIAP2 by inducing apoptosis and enhancing innate anti-tumor immunity.
Pan W; Luo Q; Yan X; Yuan L; Yi H; Zhang L; Li B; Zhang Y; Sun J; Qiu MZ; Yang DJ
Biochem Pharmacol; 2018 Aug; 154():127-135. PubMed ID: 29679556
[TBL] [Abstract][Full Text] [Related]
35. Future Therapeutic Directions for Smac-Mimetics.
Morrish E; Brumatti G; Silke J
Cells; 2020 Feb; 9(2):. PubMed ID: 32053868
[TBL] [Abstract][Full Text] [Related]
36. A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells.
Bockbrader KM; Tan M; Sun Y
Oncogene; 2005 Nov; 24(49):7381-8. PubMed ID: 16044155
[TBL] [Abstract][Full Text] [Related]
37. Benzolactam-related compounds promote apoptosis of HIV-infected human cells via protein kinase C-induced HIV latency reversal.
Matsuda K; Kobayakawa T; Tsuchiya K; Hattori SI; Nomura W; Gatanaga H; Yoshimura K; Oka S; Endo Y; Tamamura H; Mitsuya H; Maeda K
J Biol Chem; 2019 Jan; 294(1):116-129. PubMed ID: 30413535
[TBL] [Abstract][Full Text] [Related]
38. Novel second mitochondria-derived activator of caspases (Smac) mimetic compounds sensitize human leukemic cell lines to conventional chemotherapeutic drug-induced and death receptor-mediated apoptosis.
Servida F; Lecis D; Scavullo C; Drago C; Seneci P; Carlo-Stella C; Manzoni L; Polli E; Lambertenghi Deliliers G; Delia D; Onida F
Invest New Drugs; 2011 Dec; 29(6):1264-75. PubMed ID: 20614162
[TBL] [Abstract][Full Text] [Related]
39. Potent bivalent Smac mimetics: effect of the linker on binding to inhibitor of apoptosis proteins (IAPs) and anticancer activity.
Sun H; Liu L; Lu J; Bai L; Li X; Nikolovska-Coleska Z; McEachern D; Yang CY; Qiu S; Yi H; Sun D; Wang S
J Med Chem; 2011 May; 54(9):3306-18. PubMed ID: 21462933
[TBL] [Abstract][Full Text] [Related]
40. A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-kappaB.
Dai Y; Liu M; Tang W; Li Y; Lian J; Lawrence TS; Xu L
BMC Cancer; 2009 Nov; 9():392. PubMed ID: 19895686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]